title: Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
authors.forename: Harry
authors.initials: H
authors.lastname: Dao
authors.forename: Paul M
authors.initials: PM
authors.lastname: Barr
authors.forename: Kord
authors.initials: K
authors.lastname: Honda
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004167:Diphtheria Toxin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000188:drug therapy*; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox